Laurion Capital Management LP
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1390202
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,337,611
+$1,340,219 QoQ
Shares Held
4,706
+113.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#631
of 1,735 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2022CallValue
$0
CallShares
0
PutValue
$5,848,708
PutShares
20,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names. VRTX ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,352,234 | $100,714,388 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,506,152 | $67,615,980 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,820,013 | $44,417,673 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,002,701 | $15,260,581 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,900,888 | $14,751,672 | |
| 6 | IMUX |
Immunic, Inc.
|
610,326 | $9,380,710 | |
| 7 | AARD |
Aardvark Therapeutics, Inc.
|
1,034,459 | $5,958,483 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $5,306,601 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,337,611 | 4,706 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $997,392 | 2,200 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $584,962 | 1,248 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,961,942 | 66,893 | Shares | Sole | 2024-05-15 | |
| 2022-09-30 | $5,848,708 | 20,200 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $204,125 | 705 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $3,118,330 | 11,949 | Shares | Sole | 2022-05-16 | |
| 2020-09-30 | $20,130,077 | 73,975 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||